Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-UK Stocks-Factors to watch on Sept. 6

Thu, 06th Sep 2018 07:48

Sept 6 (Reuters) - Britain's FTSE 100 futures were down 0.1 percentahead of the cash market open on Thursday.

* DIXONS CARPHONE: Dixons Carphone, the troubled British electricalsand mobile phone retailer, said underlying revenue remained flat in the 13 weeksto July 28, as expected, and reiterated its full-year profittargets.

* JUST GROUP: British pensions provider Just Group Plc beatexpectations with an 85 percent jump in first-half adjusted operating profit onThursday but said it was delaying issuing a dividend due to the threat to itsfinances from proposed changes around lifetime mortgages.

* MELROSE: Turnaround specialist Melrose Industries said onThursday it had made significant progress in reorganising engineering group GKNsince its hostile 8-billion-pound takeover this year, while giving no details ofplans to break up the company.

* BURBERRY: British luxury brand Burberry said it would no longerburn millions of pounds worth of unsold goods or use real fur in its collectionsafter an uproar over its environmental credentials.

* MCCARTHY & STONE: Britain's biggest builder of homes for retirees,McCarthy & Stone, trimmed its full-year profit forecast on Thursday,months after issuing a profit warning citing cautious consumer spending andeconomic uncertainty.

* PHAUNOS TIMBER FUND: CatchMark Timber Trust Inc, a real estatecompany investing in timberlands, said it was evaluating to buy closed-endedinvestment company Phaunos Timber Fund Ltd at $0.57 pershare.

* BRITAIN-ENERGY: Britain's energy regulator proposed on Thursday a pricecap on default dual fuel energy bills of 1,136 pounds ($1,465) a year, savinghouseholds between 75 and 120 pounds a year.

* GSK: British drugmaker GlaxoSmithKline Plc said on Wednesday itwould cut about 650 positions in the United States related to a globalrestructuring program it announced in July.

* CAPITA: British outsourcer Capita has named Ismail Amla, amanaging partner at IBM's Global Services division in North America, tothe new role of chief growth officer, Sky News reported on Wednesday. http://bit.ly/2wNQxlI

* THOMAS COOK: British tour operator Thomas Cook said it had found ahigh level of e-coli and staphylococcus bacteria at the hotel in Egypt where twoholidaymakers died last month.

* LLOYDS: Lloyds Banking Group has cut 380 jobs as part of are-organisation that will also see it create 435 new roles, the bank said onWednesday, as it gears up to better compete in a market increasingly builtaround online and mobile services.

* OPHIR ENERGY: Ophir Energy is "cautiously optimistic" it willmeet a looming deadline for a final investment decision and save its stalledFortuna FLNG project in Equatorial Guinea, a senior official said on Thursday.

* RYANAIR: Ryanair is set to scrap plans to reduce its fleet inIreland after pilots there unanimously backed a deal negotiated by their tradeunion that provided a breakthrough in the airline's efforts to quell staffprotests.

* BP: The planned merger of Poland's two largest refiners PKN Orlenand Grupa Lotos could restrict competition in the east Europeancountry, BP BP.L said in a statement on Wednesday.

* EX-DIVS: Admiral Group, Antofagasta, BHP Billiton, CRH, Glencore, Land Securities Group, RSAInsurance Group, Shire will trade without entitlement to theirlatest dividend pay-out on Thursday, trimming 9.24 points off the FTSE 100according to Reuters calculations

* The UK blue chip index closed down 1 percent at 7,383.28 points onWednesday, as big oil stocks fell, though housebuilders were a bright spotfollowing comments from Berkeley Group about the London housing market.

* For more on the factors affecting European stocks, please click on: cpurl://apps.cp./cms/?pageId=livemarkets

TODAY'S UK PAPERS

> Financial Times

> Other business headlinesMultimedia versions of Reuters Top News are now available for:* For Top News : http://topnews.reuters.com(Reporting by Justin George Varghese)

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.